Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
95.01 CHF | +0.80% | +0.06% | +11.95% |
14/06 | EU regulator mandates label updates on CAR-T cancer therapies | RE |
14/06 | PeptiDream and Novartis Agreement Becomes Effective with 28.3 Billion Yen Upfront Payment | MT |
Sales 2024 * | 4.91TCr 4.37TCr 4,10300Cr | Sales 2025 * | 5.13TCr 4.56TCr 4,28200Cr | Capitalization | 22TCr 19TCr 18,16800Cr |
---|---|---|---|---|---|
Net income 2024 * | 1.04TCr 929.45Cr 87TCr | Net income 2025 * | 1.17TCr 1.04TCr 98TCr | EV / Sales 2024 * | 4.69 x |
Net Debt 2024 * | 1.27TCr 1.13TCr 1,06200Cr | Net Debt 2025 * | 1.08TCr 957.39Cr 90TCr | EV / Sales 2025 * | 4.45 x |
P/E ratio 2024 * |
20.9
x | P/E ratio 2025 * |
18.1
x | Employees | 76,057 |
Yield 2024 * |
3.43% | Yield 2025 * |
3.56% | Free-Float | 85.22% |
Latest transcript on Novartis AG
1 day | +0.80% | ||
1 week | +0.06% | ||
Current month | +1.97% | ||
1 month | +1.83% | ||
3 months | +10.94% | ||
6 months | +12.05% | ||
Current year | +11.95% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 01/05/01 | |
Director of Finance/CFO | 59 | 01/03/01 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 16/22/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 01/13/01 |
Simon Moroney
BRD | Director/Board Member | 65 | 28/20/28 |
Chairman | 68 | 01/13/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
10.40% | 121 M€ | -.--% | - | |
5.57% | 21 M€ | +8.79% | - | |
4.12% | 88 M€ | +10.37% | - | |
3.79% | 2 M€ | -25.75% |
Date | Price | Change | Volume |
---|---|---|---|
14/24/14 | 95.01 | +0.80% | 3,143,025 |
13/24/13 | 94.26 | -0.42% | 2,569,845 |
12/24/12 | 94.66 | +0.62% | 2,660,983 |
11/24/11 | 94.08 | -0.23% | 2,223,841 |
10/24/10 | 94.3 | -0.68% | 2,137,436 |
Delayed Quote Swiss Exchange, June 14, 2024 at 10:14 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.95% | 22TCr | |
+50.70% | 79TCr | |
+41.96% | 63TCr | |
-7.15% | 35TCr | |
+18.77% | 33TCr | |
+8.79% | 30TCr | |
+18.02% | 25TCr | |
+1.27% | 22TCr | |
+3.68% | 16TCr | |
-4.38% | 16TCr |
- Stock Market
- Equities
- NOVN Stock